Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon

East African Medical Journal

Volumn 86, Issue 5, 2009, Pages 219-225

  Kuaban, C ^a   Bame, R ^b   Mouangue, L ^b   Djella, S ^b   Yomgni, C ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Hopital Jamot   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; CHILD; CONFIDENCE INTERVAL; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; RISK; SPUTUM; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CAMEROON; CHILD; CONFIDENCE INTERVALS; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PROSPECTIVE STUDIES; PYRAZINAMIDE; RIFAMPIN; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77949351810     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Enarson, D.A., Rieder, H.L., Arnadottir, T. and Trebucq, A. Prise en charge de la tuberculose: guide pour les pays à faibles revenus. 5è éd Paris; Union Internationale Contre la Tuberculose et les Maladies Respiratoires, 2000.
2. World Health Organisation (WHO). Treatment of tuberculosis. Guidelines for National Programmes. 2nd ed. Geneva: WHO, 1997.
3. Rieder, H.L. Sputum smear conversion during directly observed treatment for tuberculosis. Tubercle. Lung. Dis. 1996; 77:124-129.
4. Feng-Zeng, Z., Levy, M.H. and Sumin, W. Sputum microscopy results at two months predict outcome of tuberculosis treatment. Int. J. Tuberc. Lung Dis. 1997; 1:570-572.
5. Lienhart, C., Manneh, K., Bouchier, V., et al Factors determining the outcome of treatment of adult smear-positive cases in the Gambia. Int. J. Tuberc. Lung Dis. 1998; 2:712-718.
6. Salaniponi, F.M., Christensen, J.J., Gausi, F., et al. Sputum smear status at two months and subsequent treatment outcome in new patients with smear positive pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 1999; 3:1047-1048.
7. Singla, R., Osman, M.M., Khan, N., et al. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int. J. Tuberc. Lung Dis. 2003; 7:58-64.
8. Chavez, Pachas, A.M., Blank, R., Smith, Fawzi, M.C., et al. Identifying early treatment failure on category 1 therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int. J. Tuberc. Lung Dis. 2004; 8:52-58.
9. Hobby, G.I., Holman, A.P., Iseman, M.D. and Jones J.M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob. Agents Chemother. 1973; 4:94-104.
10. Vidal, R., Martin-Casabonan, N., Juan, A., Falgueras, T. and Miravitles, M. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest. 1996; 109:1562-1565.
11. Epstein, M. D., Schluger, N. W., Davidow, A. L., et al. Time to detection of M. tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest. 1997; 113:379-386.
12. Wallis, R.S., Perkins, M.D., Philips, M. et al. Predicting the outcome of therapy for pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2000; 161:1076-1080.
13. Wallis, R.S., Perkins, M.D., Philips, M., et al. Induction of antigen 85 complex of M. tuberculosis in sputum: a determinant of outcome of therapy in pulmonary tuberculosis. J. Infect. Dis. 1998; 178:1115-1121.
14. Telzac, E.E., Fazal, B.A., Pollard, C.L., et al. Factors influencing time to sputum conversion among patients with smear positive pulmonary tuberculosis. Clin. Infect. Dis. 1997; 25: 666-670.
15. Hiyama, J., Marukawa, M., Shiota, Y., et al. Factors influencing response to treatment of pulmonary tuberculosis. Acta. Med. Okayama. 2000; 54:139-145.
16. Liu, Z., Shilkret, K.L. and Elis, H.M. Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern. Med. 1999;159:1110-1116.
17. Bwire, R., Borgdorff M.W., Sticht-Groh, V. et al. Tuberculosis chemotherapy and sputum conversion among HIV seropositive and HIV seronegative patients in south-eastern Uganda. East. Afr. Med. J. 1999;76:307-313.